In Alzheimer’s disease (AD), GMF expression is reduced and improves neuroinflammatory responses by inhibiting pro-inflammatory cytokines (TNF-α, Il-1β, and IL-1) (Ahmed et al., 2017). This evidence concerns the gene IL1B and Alzheimer disease.